Literature DB >> 33549125

Mesenchymal stem cell-originated exosomal lncRNA HAND2-AS1 impairs rheumatoid arthritis fibroblast-like synoviocyte activation through miR-143-3p/TNFAIP3/NF-κB pathway.

Yuhua Su1, Yajing Liu1, Chao Ma2, Chunxiao Guan1, Xiufen Ma1, Shan Meng3.   

Abstract

BACKGROUND: Long non-coding RNA heart and neural crest derivatives expressed 2-antisense RNA 1 (HAND2-AS1) was found to be elevated in rheumatoid arthritis (RA) fibroblast-like synoviocytes (RA-FLSs). However, whether HAND2-AS1 functions as an exosomal lncRNA related to mesenchymal stem cells (MSCs) in RA progression is unknown.
METHODS: The expression of HAND2-AS1, microRNA (miR)-143-3p, and tumor necrosis factor alpha-inducible protein 3 (TNFAIP3) was detected using quantitative real-time polymerase chain reaction and Western blot. Cell proliferation, apoptosis, migration, and invasion were detected using cell counting kit-8, flow cytometry, and wound healing and transwell assays. The levels of tumor necrosis factor-α (TNF-α) and interleukins (IL)-6 were analyzed using enzyme-linked immunosorbent assay. The level of phosphorylated-p65 was examined by Western blot. The binding interaction between miR-143-3p and HAND2-AS1 or TNFAIP3 was confirmed by the dual-luciferase reporter and RIP assays. Exosomes were isolated by ultracentrifugation and qualified by transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and Western blot.
RESULTS: HAND2-AS1 was lowly expressed in RA synovial tissues, and HAND2-AS1 re-expression suppressed the proliferation, motility, and inflammation and triggered the apoptosis in RA-FLSs via the inactivation of NF-κB pathway. Mechanistically, HAND2-AS1 directly sponged miR-143-3p and positively regulated TNFAIP3 expression, the target of miR-143-3p. Moreover, the effects of HAND2-AS1 on RA-FLSs were partially attenuated by miR-143-3p upregulation or TNFAIP3 knockdown. HAND2-AS1 could be packaged into hMSC-derived exosomes and absorbed by RA-FLSs, and human MSC-derived exosomal HAND2-AS1 also repressed above malignant biological behavior of RA-FLSs.
CONCLUSION: MSC-derived exosomes participated in the intercellular transfer of HAND2-AS1 and suppressed the activation of RA-FLSs via miR-143-3p/TNFAIP3/NF-κB pathway, which provided a novel insight into the pathogenesis and treatment of RA.

Entities:  

Keywords:  Exosomes; HAND2-AS1; Mesenchymal stem cells; Rheumatoid arthritis; TNFAIP3; miR-143-3p

Mesh:

Substances:

Year:  2021        PMID: 33549125      PMCID: PMC7866436          DOI: 10.1186/s13018-021-02248-1

Source DB:  PubMed          Journal:  J Orthop Surg Res        ISSN: 1749-799X            Impact factor:   2.359


  38 in total

Review 1.  Implications of the noncoding RNAs in rheumatoid arthritis pathogenesis.

Authors:  Mohammad Javad Mousavi; Ahmadreza Jamshidi; Arvind Chopra; Saeed Aslani; Massoomeh Akhlaghi; Mahdi Mahmoudi
Journal:  J Cell Physiol       Date:  2018-08-01       Impact factor: 6.384

Review 2.  Exosome mediated communication within the tumor microenvironment.

Authors:  Lara Milane; Amit Singh; George Mattheolabakis; Megha Suresh; Mansoor M Amiji
Journal:  J Control Release       Date:  2015-07-02       Impact factor: 9.776

Review 3.  Rheumatoid arthritis progression mediated by activated synovial fibroblasts.

Authors:  Elena Neumann; Stephanie Lefèvre; Birgit Zimmermann; Steffen Gay; Ulf Müller-Ladner
Journal:  Trends Mol Med       Date:  2010-08-24       Impact factor: 11.951

Review 4.  Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis.

Authors:  Beatrix Bartok; Gary S Firestein
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

Review 5.  CircRNA: a novel type of biomarker for cancer.

Authors:  He-da Zhang; Lin-Hong Jiang; Da-Wei Sun; Jun-Chen Hou; Zhen-Ling Ji
Journal:  Breast Cancer       Date:  2017-07-18       Impact factor: 4.239

6.  Combination of Collagen-Based Scaffold and Bioactive Factors Induces Adipose-Derived Mesenchymal Stem Cells Chondrogenic Differentiation In vitro.

Authors:  Giovanna Calabrese; Stefano Forte; Rosario Gulino; Francesco Cefalì; Elisa Figallo; Lucia Salvatorelli; Eugenia T Maniscalchi; Giuseppe Angelico; Rosalba Parenti; Massimo Gulisano; Lorenzo Memeo; Raffaella Giuffrida
Journal:  Front Physiol       Date:  2017-02-02       Impact factor: 4.566

7.  A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.

Authors:  Jiajia Feng; Qinyi Zhou; Hongliang Yi; Shiyin Ma; Dawei Li; Yanan Xu; Jiadong Wang; Shankai Yin
Journal:  Cell Death Dis       Date:  2019-06-03       Impact factor: 8.469

Review 8.  LncRNA-mediated regulation of cell signaling in cancer.

Authors:  W-X Peng; P Koirala; Y-Y Mo
Journal:  Oncogene       Date:  2017-06-12       Impact factor: 9.867

9.  Cell-free Stem Cell-Derived Extract Formulation for Regenerative Medicine Applications.

Authors:  Ashim Gupta; Craig Cady; Anne-Marie Fauser; Hugo C Rodriguez; R Justin Mistovich; Anish G R Potty; Nicola Maffulli
Journal:  Int J Mol Sci       Date:  2020-12-09       Impact factor: 5.923

View more
  8 in total

1.  Exosomes Derived from lncRNA TCTN2-Modified Mesenchymal Stem Cells Improve Spinal Cord Injury by miR-329-3p/IGF1R Axis.

Authors:  Jian Liu; Mingxia Lin; Feng Qiao; Chenghua Zhang
Journal:  J Mol Neurosci       Date:  2021-10-08       Impact factor: 3.444

Review 2.  Mesenchymal Stem Cell-Derived Extracellular Vesicles as Non-Coding RNA Therapeutic Vehicles in Autoimmune Diseases.

Authors:  Olga Martinez-Arroyo; Ana Ortega; Maria J Forner; Raquel Cortes
Journal:  Pharmaceutics       Date:  2022-03-29       Impact factor: 6.525

Review 3.  Cell-based therapies for rheumatoid arthritis: opportunities and challenges.

Authors:  Yu-Jing Li; Zhu Chen
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-23       Impact factor: 3.625

Review 4.  Promising Therapeutic Targets for Treatment of Rheumatoid Arthritis.

Authors:  Jie Huang; Xuekun Fu; Xinxin Chen; Zheng Li; Yuhong Huang; Chao Liang
Journal:  Front Immunol       Date:  2021-07-09       Impact factor: 7.561

5.  Bone marrow mesenchymal stem cells-derived exosomes suppress miRNA-5189-3p to increase fibroblast-like synoviocyte apoptosis via the BATF2/JAK2/STAT3 signaling pathway.

Authors:  Yiqun Zhang; Bizhi Tu; Qi Sha; Jun Qian
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 6.  Adipose-Derived Stem Cell Exosomes as a Novel Anti-Inflammatory Agent and the Current Therapeutic Targets for Rheumatoid Arthritis.

Authors:  Ting-Hui Chang; Chien-Sheng Wu; Shih-Hwa Chiou; Chih-Hung Chang; Hsiu-Jung Liao
Journal:  Biomedicines       Date:  2022-07-18

Review 7.  The Expression of Non-Coding RNAs and Their Target Molecules in Rheumatoid Arthritis: A Molecular Basis for Rheumatoid Pathogenesis and Its Potential Clinical Applications.

Authors:  Chang-Youh Tsai; Song-Chou Hsieh; Chih-Wei Liu; Cheng-Hsun Lu; Hsien-Tzung Liao; Ming-Han Chen; Ko-Jen Li; Cheng-Han Wu; Cheih-Yu Shen; Yu-Min Kuo; Chia-Li Yu
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 8.  A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine.

Authors:  Soudeh Moghadasi; Marischa Elveny; Heshu Sulaiman Rahman; Wanich Suksatan; Abduladheem Turki Jalil; Walid Kamal Abdelbasset; Alexei Valerievich Yumashev; Siavash Shariatzadeh; Roza Motavalli; Farahnaz Behzad; Faroogh Marofi; Ali Hassanzadeh; Yashwant Pathak; Mostafa Jarahian
Journal:  J Transl Med       Date:  2021-07-12       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.